Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia–reperfusion injury
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia–reperfusion injury
Authors
Keywords
Mitochondrial Permeability Transition Pore, Reactive Oxygen Species Burst, ADMSC Treatment, Acute Kidney Ischemia, Oxyblot Oxidize Protein Detection
Journal
Stem Cell Research & Therapy
Volume 4, Issue 3, Pages 62
Publisher
Springer Nature
Online
2013-05-31
DOI
10.1186/scrt212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic exposure to environmental contaminant nonylphenol exacerbates adenine-induced chronic renal insufficiency: Role of signaling pathways and therapeutic impact of rosuvastatin
- (2012) Chia-Hung Yen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Combination of cyclosporine and erythropoietin improves brain infarct size and neurological function in rats after ischemic stroke
- (2011) Chun-Man Yuen et al. Journal of Translational Medicine
- Autologous Transplantation of Adipose-Derived Mesenchymal Stem Cells Markedly Reduced Acute Ischemia-Reperfusion Lung Injury in a Rodent Model
- (2011) Cheuk-Kwan Sun et al. Journal of Translational Medicine
- Adipose-Derived Mesenchymal Stem Cell Protects Kidneys against Ischemia-Reperfusion Injury through Suppressing Oxidative Stress and Inflammatory Reaction
- (2011) Yen-Ta Chen et al. Journal of Translational Medicine
- Human adipose tissue−derived mesenchymal stem cells facilitate the immunosuppressive effect of cyclosporin A on T lymphocytes through Jagged-1−mediated inhibition of NF-κB signaling
- (2010) Dan Shi et al. EXPERIMENTAL HEMATOLOGY
- Autologous bone marrow cell implantation attenuates left ventricular remodeling and improves heart function in porcine myocardial infarction: An echocardiographic, six-month angiographic, and molecular–cellular study
- (2010) Steve Leu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Renal Acute Cellular Rejection: Correlation Between the Immunophenotype and Cytokine Expression of the Inflammatory Cells in Acute Glomerulitis, Arterial Intimitis, and Tubulointerstitial Nephritis
- (2010) A. Sementilli et al. TRANSPLANTATION PROCEEDINGS
- The role of the mitochondrial permeability transition pore in heart disease
- (2009) Andrew P. Halestrap et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Bone marrow–derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy*
- (2009) Cheuk-Kwan Sun et al. CRITICAL CARE MEDICINE
- Inhibition of Mitochondrial Membrane Permeability as a Putative Pharmacological Target for Cardioprotection
- (2009) D. Morin et al. CURRENT MEDICINAL CHEMISTRY
- Intra-coronary administration of cyclosporine limits infarct size, attenuates remodeling and preserves left ventricular function in porcine acute anterior infarction
- (2009) Jiunn-Jye Sheu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Mitochondrial Permeability Transition Pore Opening as a Promising Therapeutic Target in Cardiac Diseases
- (2009) S. Javadov et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Long-term Prognosis of Acute Kidney Injury After Acute Myocardial Infarction
- (2008) Chirag R. Parikh et al. ARCHIVES OF INTERNAL MEDICINE
- Autologous Bone Marrow-Derived Mononuclear Cell Therapy Prevents the Damage of Viable Myocardium and Improves Rat Heart Function Following Acute Anterior Myocardial Infarction
- (2008) Hon-Kan Yip et al. CIRCULATION JOURNAL
- Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
- (2008) Christophe Piot et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More